logo
Select company
Select metric
$ -49.38MEarning Before Interest & Taxes (EBIT)
VS
Market
16
Sector
36
Industry
49
History
33
$ 0.15Close
$ 0.15 - $ 1.11 52-Week Range
Ticker Information

Ticker

CARM

Company Name

CARISMA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARISMA THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CARM - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -49.38M
3/31/2025$ -51.27M
12/31/2024$ -60.48M
9/30/2024$ -66.33M
6/30/2024$ -75.97M
3/31/2024$ -85.27M
12/31/2023$ -88.81M
9/30/2023$ -73.94M
6/30/2023$ -31.15M
3/31/2023$ -46.02M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -39.81M.
  • Over the past 5 years, CARISMA THERAPEUTICS INC's average EBIT has been $ -45.74M.
  • The median EBIT for CARISMA THERAPEUTICS INC during this period was $ -47.7M
  • CARISMA THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ 45.76M.
  • The lowest EBIT recorded by CARISMA THERAPEUTICS INC in the same timeframe $ -117.74M

CARISMA THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
CSCIF : COSCIENS BIOPHARMA INC $ -17.73MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MJAGX : JAGUAR HEALTH INC $ -40.99MVSEE : VSEE HEALTH INC $ -59.13MTRAW : TRAWS PHARMA INC $ 87.91MCRIS : CURIS INC $ -38.92MMRKR : MARKER THERAPEUTICS INC $ -14.56MLGVN : LONGEVERON INC $ -18.54MCYCN : CYCLERION THERAPEUTICS INC $ -1.95MLYRA : LYRA THERAPEUTICS INC $ -38.82M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

CARM - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -117.74M

Minimum

Mar 31, 2021

$ 45.76M

Maximum

Mar 31, 2022

$ -45.74M

Average

$ -47.7M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.79M with a standard deviation of $ 130.84M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.79M
median$ 971K
std$ 130.84M